BIOMEDITECH ApS: Financial statements 2019
CVR: 34707847
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -13,184 compared with DKK -17,579 the year before. Equity in the 2019 report amounted to DKK 34,165. The solvency ratio was 86.4%.
- Profit/Loss
- DKK -13,184
- Equity
- DKK 34,165
- Total Assets
- DKK 39,553
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -13K | 34K | - |
| 2018 | - | - | -18K | 47K | - |
| 2017 | - | - | -28K | 65K | - |
| 2016 | - | - | -31K | 93K | - |
| 2015 | 0 | 0 | 0 | 124K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BIOMEDITECH ApS has published its annual report for 2018. The net result was DKK -17,579.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.